Newer treatment studies for bipolar depression (Q34459611)

2 August 2017

1 reference

title

Newer treatment studies for bipolar depression (English)

1 reference

2 August 2017

1 reference

2

Joseph R Calabrese

1 reference

2 August 2017

Keming Gao

1

1 reference

2 August 2017

publication date

1 January 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

7 Suppl 5

1 reference

2 August 2017

page(s)

13-23

1 reference

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A review of psychosocial outcome in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Inositol as an add-on treatment for bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Fish consumption and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Lack of seasonal mood change in Icelanders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Maintenance efficacy of divalproex in the prevention of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

Local Origin of Fibroblasts deduced from Sarcomas induced in Chimaeras by Implants of Pliable Disks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-5618.2005.00250.X

10.1111/J.1399-5618.2005.00250.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference